This Article  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

JAMES R. CHANDLER, MD
Miami

Arch Otolaryngol. 1980;106(7):445.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

To the Editor.—Sodium fluoride is now being given to patients for the treatment of vertigo, for sensorineural hearing losses, and for tinnitus. In other words, it is being suggested as a logical and rational treatment for those patients with the classic symptoms of Ménière's disease. All of this, of course, is based on the theoretical possibility that otospongiosis, with its histopathological and biochemical changes, is capable of affecting the inner ear and can be demonstrated by current roentgenographic means. This is an illogical and perhaps dangerous trend in thought.

It has only been several decades since otologists, on encountering a patient with no obvious ear disease and a substantial conductive hearing loss, made the diagnosis of "clinical otosclerosis." This was because the disease could not be proved by histopathological examination of excised tissue. It was only after fixation of the footplate had been demonstrated unequivocally at surgery in the . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?